Covering IPOs, Healthcare and Technology Stocks

Andrei Zakharov

A highly collaborative investment professional and research analyst with 10+ years of international experience in equity research, treasury operations, and trading positions across multiple asset classes at leading multinational banks Citibank and Morgan Stanley, UHNWI-backed family office and European independent equity research firm. A respectable background in equity capital markets, corporate treasury, investment banking operations, equity research analysis and portfolio management.

Algosun Global

Equity Capital Markets

<p><a href="https://www.smartkarma.com/entities/candela-medical" target="_blank" data-smartkarma-citation="entities:34483:1" rel="noopener">Candela Medical (CDLA US)</a> , pioneer and leader in medical aesthetics market, announced terms of upcoming IPO. A non-surgical aesthetic device company to offer ~14.7 million shares at expected price range of $16-$18 per share, what implies a market cap of ~$1.7 billion at midpoint of the price range. This is the second IPO of leading player in global aesthetics market for the last two years after InMode went public in 2019 and the shares rose more than fivefold since IPO. Candela Medical shares are expected to begin trading on Nasdaq Global Market under the trading symbol “CDLA”. Bank of America, Goldman Sachs and Barclays are leading the IPO.</p>

Candela Medical (CDLA US) , pioneer and leader in medical aesthetics market, announced terms of upcoming IPO. A non-surgical aesthetic device company to offer ~14.7 million shares at expected price range of $16-$18 per share, what implies a market cap of ~$1.7 billion at midpoint of the price range. This is the second IPO of leading player in global aesthetics market for the last two years after InMode went public in 2019 and the shares rose more than fivefold since IPO. Candela Medical shares are expected to begin trading on Nasdaq Global Market under the trading symbol “CDLA”. Bank of America, Goldman Sachs and Barclays are leading the IPO.

Candela Medical IPO: InMode’s Competitor Filed To Go Public